Exact Mass: 613.29

6-Oxoneomycin C

C23H43N5O14 (613.2806)

Ferrioxamine B

C25H45FeN6O8 (613.2648)

Ferrioxamine b belongs to the class of organic compounds known as n-acyl amines. N-acyl amines are compounds containing a fatty acid moiety linked to an amine group through an ester linkage. Ferrioxamine b is considered to be a practically insoluble (in water) and relatively neutral molecule. Ferrioxamine b exists in all living organisms, ranging from bacteria to humans.

(Stearoyl)adenylate

C28H48N5O8P (613.324)

Pervilleine D

C32H39NO11 (613.2523)

Oleficin

C34H47NO9 (613.3251)

Chasmaconitine

C34H47NO9 (613.3251)

Guineamide A

C31H43N5O6S (613.2934)

Phoslactomycin C

C30H48NO10P (613.3016)

C34H47NO9

C34H47NO9 (613.3251)

3beta-hydroxynorerythrosuamine 3-O-beta-D-glucopyranoside hydrochloride

C30H47NO12 (613.3098)

(1alpha,6alpha,14alpha)-8-acetoxy-13-hydroxy-1,6,16-trimethoxy-4-(methoxymethyl)aconitan-14-yl 4-methoxybenzoate|macrorhynine B

C33H43NO10 (613.2887)

rhizoxin S1

C34H47NO9 (613.3251)

15-O-methylenigmazole A

C30H48NO10P (613.3016)

Myrsinol-type diterpene ester CPB51-719-2

C32H39NO11 (613.2523)

C30H47NO12

C30H47NO12 (613.3098)

Met Val His Leu Thr

C27H47N7O7S (613.3258)

Phe Ile Phe Met Gly

C31H43N5O6S (613.2934)

His Val Thr Glu Glu

C25H39N7O11 (613.2707)

CID 154831998

C34H47NO9 (613.3251)

Ferrioxamine B [M+Fe-2H]

C25H45FeN6O8 (613.2648)

Asp Phe Phe Trp

C33H35N5O7 (613.2536)

Asp Phe Trp Phe

C33H35N5O7 (613.2536)

Asp Trp Phe Phe

C33H35N5O7 (613.2536)

Glu Phe Arg Tyr

C29H39N7O8 (613.286)

Glu Phe Tyr Arg

C29H39N7O8 (613.286)

Glu Arg Phe Tyr

C29H39N7O8 (613.286)

Glu Arg Tyr Phe

C29H39N7O8 (613.286)

Glu Tyr Phe Arg

C29H39N7O8 (613.286)

Glu Tyr Arg Phe

C29H39N7O8 (613.286)

Phe Asp Phe Trp

C33H35N5O7 (613.2536)

Phe Asp Trp Phe

C33H35N5O7 (613.2536)

Phe Glu Arg Tyr

C29H39N7O8 (613.286)

Phe Glu Tyr Arg

C29H39N7O8 (613.286)

Phe Phe Asp Trp

C33H35N5O7 (613.2536)

Phe Phe Trp Asp

C33H35N5O7 (613.2536)

Phe Arg Glu Tyr

C29H39N7O8 (613.286)

Phe Arg Tyr Glu

C29H39N7O8 (613.286)

Phe Val Trp Tyr

C34H39N5O6 (613.29)

Phe Val Tyr Trp

C34H39N5O6 (613.29)

Phe Trp Asp Phe

C33H35N5O7 (613.2536)

Phe Trp Phe Asp

C33H35N5O7 (613.2536)

Phe Trp Val Tyr

C34H39N5O6 (613.29)

Phe Trp Tyr Val

C34H39N5O6 (613.29)

Phe Tyr Glu Arg

C29H39N7O8 (613.286)

Phe Tyr Arg Glu

C29H39N7O8 (613.286)

Phe Tyr Val Trp

C34H39N5O6 (613.29)

Phe Tyr Trp Val

C34H39N5O6 (613.29)

Ile Arg Tyr Tyr

C30H43N7O7 (613.3224)

Ile Tyr Arg Tyr

C30H43N7O7 (613.3224)

Ile Tyr Tyr Arg

C30H43N7O7 (613.3224)

Leu Arg Tyr Tyr

C30H43N7O7 (613.3224)

Leu Tyr Arg Tyr

C30H43N7O7 (613.3224)

Leu Tyr Tyr Arg

C30H43N7O7 (613.3224)

Arg Glu Phe Tyr

C29H39N7O8 (613.286)

Arg Glu Tyr Phe

C29H39N7O8 (613.286)

Arg Phe Glu Tyr

C29H39N7O8 (613.286)

Arg Phe Tyr Glu

C29H39N7O8 (613.286)

Arg Ile Tyr Tyr

C30H43N7O7 (613.3224)

Arg Leu Tyr Tyr

C30H43N7O7 (613.3224)

Arg Tyr Glu Phe

C29H39N7O8 (613.286)

Arg Tyr Phe Glu

C29H39N7O8 (613.286)

Arg Tyr Ile Tyr

C30H43N7O7 (613.3224)

Arg Tyr Leu Tyr

C30H43N7O7 (613.3224)

Arg Tyr Tyr Ile

C30H43N7O7 (613.3224)

Arg Tyr Tyr Leu

C30H43N7O7 (613.3224)

Val Phe Trp Tyr

C34H39N5O6 (613.29)

Val Phe Tyr Trp

C34H39N5O6 (613.29)

Val Trp Phe Tyr

C34H39N5O6 (613.29)

Val Trp Tyr Phe

C34H39N5O6 (613.29)

Val Tyr Phe Trp

C34H39N5O6 (613.29)

Val Tyr Trp Phe

C34H39N5O6 (613.29)

Trp Asp Phe Phe

C33H35N5O7 (613.2536)

Trp Phe Asp Phe

C33H35N5O7 (613.2536)

Trp Phe Phe Asp

C33H35N5O7 (613.2536)

Trp Phe Val Tyr

C34H39N5O6 (613.29)

Trp Phe Tyr Val

C34H39N5O6 (613.29)

Trp Val Phe Tyr

C34H39N5O6 (613.29)

Trp Val Tyr Phe

C34H39N5O6 (613.29)

Trp Tyr Phe Val

C34H39N5O6 (613.29)

Trp Tyr Val Phe

C34H39N5O6 (613.29)

Tyr Glu Phe Arg

C29H39N7O8 (613.286)

Tyr Glu Arg Phe

C29H39N7O8 (613.286)

Tyr Phe Glu Arg

C29H39N7O8 (613.286)

Tyr Phe Arg Glu

C29H39N7O8 (613.286)

Tyr Phe Val Trp

C34H39N5O6 (613.29)

Tyr Phe Trp Val

C34H39N5O6 (613.29)

Tyr Ile Arg Tyr

C30H43N7O7 (613.3224)

Tyr Ile Tyr Arg

C30H43N7O7 (613.3224)

Tyr Leu Arg Tyr

C30H43N7O7 (613.3224)

Tyr Leu Tyr Arg

C30H43N7O7 (613.3224)

Tyr Arg Glu Phe

C29H39N7O8 (613.286)

Tyr Arg Phe Glu

C29H39N7O8 (613.286)

Tyr Arg Ile Tyr

C30H43N7O7 (613.3224)

Tyr Arg Leu Tyr

C30H43N7O7 (613.3224)

Tyr Arg Tyr Ile

C30H43N7O7 (613.3224)

Tyr Arg Tyr Leu

C30H43N7O7 (613.3224)

Tyr Val Phe Trp

C34H39N5O6 (613.29)

Tyr Val Trp Phe

C34H39N5O6 (613.29)

Tyr Trp Phe Val

C34H39N5O6 (613.29)

Tyr Trp Val Phe

C34H39N5O6 (613.29)

Tyr Tyr Ile Arg

C30H43N7O7 (613.3224)

Tyr Tyr Leu Arg

C30H43N7O7 (613.3224)

Tyr Tyr Arg Ile

C30H43N7O7 (613.3224)

Tyr Tyr Arg Leu

C30H43N7O7 (613.3224)

FIFMG

C31H43N5O6S (613.2934)

HVTEE

C25H39N7O11 (613.2707)

AMP 18:0

C28H48N5O8P (613.324)

5-[4,5-DIHYDRO-5-OXO-3-[(1-OXOOCTADECYL)AMINO]-1H-PYRAZOL-1-YL]-2-PHENOXY-BENZENESULFONIC ACID

C33H47N3O6S (613.3185)

TAE684(NVP-TAE684)

C30H40ClN7O3S (613.2602)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C141136 - ALK Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

Skinasensyl

C34H39N5O6 (613.29)

Acetyl tetrapeptide-15 is a synthetic peptide used in the cosmetics for sensitive skin. Acetyl tetrapeptide-15 is derived from endomorphin-2 (Tyr-Pro-Phe-Phe-NH2), a human μ-opioid agonist with selective anti-nociceptive effect. Acetyl tetrapeptide-15 reduces skin hyperreactivity producing inflammatory, chronic and neuropathic pain, by increasing the threshold of neuronal excitability in μ-opioid receptor via an endorphin-like pathway[1]. Acetyl tetrapeptide-15 is a synthetic peptide used in the cosmetics for sensitive skin. Acetyl tetrapeptide-15 is derived from endomorphin-2 (Tyr-Pro-Phe-Phe-NH2), a human μ-opioid agonist with selective anti-nociceptive effect. Acetyl tetrapeptide-15 reduces skin hyperreactivity producing inflammatory, chronic and neuropathic pain, by increasing the threshold of neuronal excitability in μ-opioid receptor via an endorphin-like pathway[1].

Aplaviroc hydrochloride

C33H44ClN3O6 (613.2918)

C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist

N-(Ethylsulfonyl)-5-propoxy-L-tryptophyl-N~1~-{4-[amino(imino)methyl]benzyl}-L-glutamamide

C29H39N7O6S (613.2682)

Euphorbia diterpenoid 2

C32H39NO11 (613.2523)

A tetracyclic diterpenoid isolated from the whole plant of Euphorbia decipiens and exhibits inhibitory activity against urease.

Ffglm-NH2(1+)

C31H45N6O5S+ (613.3172)

1-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-phenylurea

C31H34F3N5O5 (613.2512)

3-(4-fluorophenyl)-1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea

C34H36FN5O5 (613.27)

3-(4-fluorophenyl)-1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea

C34H36FN5O5 (613.27)

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide

C33H39N7O5 (613.3013)

N-(2-aminophenyl)-4-[[[(2R,3S)-9-[[cyclopropyl(oxo)methyl]amino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzamide

C35H43N5O5 (613.3264)

N-(2-aminophenyl)-4-[[[(2S,3R)-9-[[cyclopropyl(oxo)methyl]amino]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzamide

C35H43N5O5 (613.3264)

3-(4-fluorophenyl)-1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea

C34H36FN5O5 (613.27)

N-(2-aminophenyl)-4-[[[(2R,3R)-9-[[cyclopropyl(oxo)methyl]amino]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzamide

C35H43N5O5 (613.3264)

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C31H34F3N5O5 (613.2512)

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C31H34F3N5O5 (613.2512)

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C31H34F3N5O5 (613.2512)

N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide

C33H39N7O5 (613.3013)

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C31H34F3N5O5 (613.2512)

N-(2-aminophenyl)-4-[[[(2R,3S)-9-[[cyclopropyl(oxo)methyl]amino]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzamide

C35H43N5O5 (613.3264)

N-(2-aminophenyl)-4-[[[(2S,3R)-9-[[cyclopropyl(oxo)methyl]amino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzamide

C35H43N5O5 (613.3264)

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide

C33H39N7O5 (613.3013)

3-(4-fluorophenyl)-1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea

C34H36FN5O5 (613.27)

3-(4-fluorophenyl)-1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea

C34H36FN5O5 (613.27)

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide

C33H39N7O5 (613.3013)

N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide

C33H39N7O5 (613.3013)

N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide

C33H39N7O5 (613.3013)

SHexCer 21:1;3O

C27H51NO12S (613.3132)

Lnaps 20:5/N-4:0

C30H48NO10P (613.3016)

Lnaps 22:5/N-2:0

C30H48NO10P (613.3016)

Lnaps 2:0/N-22:5

C30H48NO10P (613.3016)

Lnaps 4:0/N-20:5

C30H48NO10P (613.3016)

2-amino-3-[[3-butanoyloxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C30H48NO10P (613.3016)

2-amino-3-[[3-hexanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C30H48NO10P (613.3016)

3-[[3-acetyloxy-2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxy-2-aminopropanoic acid

C30H48NO10P (613.3016)

Ferroxamine

C25H45FeN6O8 (613.2648)

A Fe(III)-complexed hydroxamate siderophore comprising equimolar amounts of iron(3+) and desferrioxamine B(3-)

6'''-Oxoneomycin C

C23H43N5O14 (613.2806)

Oxoneomycin C

C23H43N5O14 (613.2806)

PC 18:4/5:1;O

C31H52NO9P (613.338)

PC 23:5;O

C31H52NO9P (613.338)

LNAPE 26:5;O

C31H52NO9P (613.338)

PE O-26:6;O2

C31H52NO9P (613.338)

PE P-18:1/8:4;O2

C31H52NO9P (613.338)

PE 18:2/8:3;O

C31H52NO9P (613.338)

PE 18:3/7:3;O2

C30H48NO10P (613.3016)

PE 18:4/7:2;O2

C30H48NO10P (613.3016)

PE 18:4/8:1;O

C31H52NO9P (613.338)

PE 20:3/6:2;O

C31H52NO9P (613.338)

PE 20:5/5:1;O2

C30H48NO10P (613.3016)

PE 22:4/4:1;O

C31H52NO9P (613.338)

PE 25:6;O2

C30H48NO10P (613.3016)

PE 26:5;O

C31H52NO9P (613.338)

LNAPS 23:6;O

C29H44NO11P (613.2652)

LNAPS 24:5

C30H48NO10P (613.3016)

PS 20:4/4:1

C30H48NO10P (613.3016)

PS 20:5/4:0

C30H48NO10P (613.3016)

PS 22:5/2:0

C30H48NO10P (613.3016)

PS 24:5

C30H48NO10P (613.3016)

SHexCer 21:1;O3

C27H51NO12S (613.3132)

ST 21:3;O8;HexNAc

C29H43NO13 (613.2734)

ST 22:2;O7;HexNAc

C30H47NO12 (613.3098)

ST 25:7;O5;HexNAc

C33H43NO10 (613.2887)

ST 26:6;O4;HexNAc

C34H47NO9 (613.3251)

ST 28:4;O7;Tau

C30H47NO10S (613.2921)

ST 29:3;O6;Tau

C31H51NO9S (613.3284)

methyl (1r,2s,4ar,4bs,7e,8r,8as,9r,10ar)-9-hydroxy-7-{[(2-hydroxyethyl)(methyl)carbamoyl]methylidene}-1,4a,8-trimethyl-10-oxo-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydrophenanthrene-1-carboxylate

C30H47NO12 (613.3098)

methyl (4s)-4-(3-acetyl-2,6-dihydroxyphenyl)-4-(3-{[(2s,5r)-5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]methyl}-1h-indol-2-yl)-2-methoxybutanoate

C34H35N3O8 (613.2424)

3-(4-{15-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-1-hydroxy-12,14,16-trimethylheptadeca-2,4,6,8,10,12-hexaen-1-ylidene}-1-methyl-3,5-dioxopyrrolidin-2-yl)propanoic acid

C34H47NO9 (613.3251)

{2,12-dihydroxy-4-[3-hydroxy-4,8-dimethyl-9-(2-methyl-1,3-oxazol-4-yl)nona-4,6,8-trien-2-yl]-1,13-dimethyl-6-oxo-5,17-dioxabicyclo[14.1.0]heptadeca-7,14-dien-10-yl}acetic acid

C34H47NO9 (613.3251)

{11-methoxy-9-[2-(3-methoxy-2-methylbut-1-en-1-yl)-1,3-oxazol-4-yl]-4,6-dimethyl-17-methylidene-7-oxo-8,19-dioxabicyclo[13.3.1]nonadecan-3-yl}oxyphosphonic acid

C30H48NO10P (613.3016)

methyl (1r,2s,4ar,4bs,7e,8r,8as,9r,10ar)-9-hydroxy-1,4a,8-trimethyl-7-{2-[2-(methylamino)ethoxy]-2-oxoethylidene}-10-oxo-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydrophenanthrene-1-carboxylate

C30H47NO12 (613.3098)

(3s,6s,7r)-6-hydroxy-8-methyl-7-{[(2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl (2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate

C32H39NO11 (613.2523)

(1s,2r,3r,4r,5s,6s,8r,9r,10r,13s,16s,17r,18r)-8-(acetyloxy)-11-ethyl-5-hydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

C34H47NO9 (613.3251)

(1s,2r,3r,4r,5s,6s,8r,9r,10r,13s,16s,17r,18r)-8-(acetyloxy)-5-hydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-en-4-yl 4-methoxybenzoate

C33H43NO10 (613.2887)

(2s,5s,8s,11s,14s,15r)-5-benzyl-15-ethyl-4,17-dihydroxy-8-isopropyl-2,6,9,11,14-pentamethyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

C31H43N5O6S (613.2934)

[(1e,7e,9e)-3-(2-aminoethyl)-1-(3-ethyl-6-oxo-2,3-dihydropyran-2-yl)-3,6-dihydroxy-10-{3-[(2-methylbutanoyl)oxy]cyclohexyl}deca-1,7,9-trien-4-yl]oxyphosphonic acid

C30H48NO10P (613.3016)

5-benzyl-15-ethyl-4,17-dihydroxy-8-isopropyl-2,6,9,11,14-pentamethyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione

C31H43N5O6S (613.2934)

(1r,3s,5s,6r,7s)-6-hydroxy-8-methyl-7-{[(2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl (2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate

C32H39NO11 (613.2523)

(1s,2r,3r,4s,5s,6s,8r,9r,10r,13s,16r,17r,18r)-8-(acetyloxy)-11-ethyl-5-hydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

C34H47NO9 (613.3251)

(2r,3r,6s,8r,9r,10s,13s,17r)-8-(acetyloxy)-11-formyl-5-hydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

C33H43NO10 (613.2887)

8-(acetyloxy)-5-hydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-en-4-yl 4-methoxybenzoate

C33H43NO10 (613.2887)

[(1r,3s,4s,6s,9s,11s,15r)-11-methoxy-9-{2-[(1e,3r)-3-methoxy-2-methylbut-1-en-1-yl]-1,3-oxazol-4-yl}-4,6-dimethyl-17-methylidene-7-oxo-8,19-dioxabicyclo[13.3.1]nonadecan-3-yl]oxyphosphonic acid

C30H48NO10P (613.3016)

3-[(2r)-4-[(2e,4e,6e,8z,10z,12e,14r,15s)-15-{[(2r,4r,5r,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-12,14,16-trimethylheptadeca-2,4,6,8,10,12-hexaenoyl]-3-hydroxy-1-methyl-5-oxo-2h-pyrrol-2-yl]propanoic acid

C34H47NO9 (613.3251)

3-{4-[(2e,4e,6e,8e,10e,12e)-15-{[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-12,14,16-trimethylheptadeca-2,4,6,8,10,12-hexaenoyl]-5-hydroxy-1-methyl-3-oxo-2h-pyrrol-2-yl}propanoic acid

C34H47NO9 (613.3251)

methyl 9-hydroxy-1,4a,8-trimethyl-7-{2-[2-(methylamino)ethoxy]-2-oxoethylidene}-10-oxo-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydrophenanthrene-1-carboxylate

C30H47NO12 (613.3098)

6-hydroxy-8-methyl-7-{[3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 3-(3,4,5-trimethoxyphenyl)prop-2-enoate

C32H39NO11 (613.2523)

[(1e,7e,9e)-3-(2-aminoethyl)-1-(3-ethyl-6-oxo-2,3-dihydropyran-2-yl)-3,6-dihydroxy-10-{3-[(3-methylbutanoyl)oxy]cyclohexyl}deca-1,7,9-trien-4-yl]oxyphosphonic acid

C30H48NO10P (613.3016)

3-[(4z)-4-[(2e,4e,6e,8e,10e,12e)-15-{[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-1-hydroxy-12,14,16-trimethylheptadeca-2,4,6,8,10,12-hexaen-1-ylidene]-1-methyl-3,5-dioxopyrrolidin-2-yl]propanoic acid

C34H47NO9 (613.3251)

methyl 9-hydroxy-7-{[(2-hydroxyethyl)(methyl)carbamoyl]methylidene}-1,4a,8-trimethyl-10-oxo-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-decahydrophenanthrene-1-carboxylate

C30H47NO12 (613.3098)

[(1r,2s,4s,7e,10r,12r,13r,14e,16r)-2,12-dihydroxy-4-[(2r,3r,4e,6e,8e)-3-hydroxy-4,8-dimethyl-9-(2-methyl-1,3-oxazol-4-yl)nona-4,6,8-trien-2-yl]-1,13-dimethyl-6-oxo-5,17-dioxabicyclo[14.1.0]heptadeca-7,14-dien-10-yl]acetic acid

C34H47NO9 (613.3251)

3-[(2r)-4-[(2e,4e,6e,8z,10z,12e,14r,15s)-15-{[(2r,4r,5r,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-1-hydroxy-12,14,16-trimethylheptadeca-2,4,6,8,10,12-hexaen-1-ylidene]-1-methyl-3,5-dioxopyrrolidin-2-yl]propanoic acid

C34H47NO9 (613.3251)

8-(acetyloxy)-11-ethyl-5-hydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

C34H47NO9 (613.3251)